An interview with three distinguished members of ASPET about the society, and how it helped them navigate their careers. As our field adapts to new technologies, unpredictable federal policies, and evolving academic structures, ASPET must similarly adapt to best serve our members. As these three interviews with distinguished ASPET members makes clear, change is something that every scientist must expect, and membership in ASPET can be an invaluable aid in both developing career paths and furthering research.
ASPET Executive Officer Dave Jackson shares how this issue’s cover story illustrates the ways membership in ASPET can help scientists throughout their careers, as well as the importance of attending ASPET 2026 in Minneapolis. He also discusses how membership in ASPET supports scientists, through grants, community, publication opportunities, networking, and more.
Professor Des Richardson Recognized for Leadership, ASPET Welcomes New Members.
Honoring ASPET members who have passed.
On October 14, 2025, ASPET joined 21 other organizations to participate in the People for Effective and Ethical Research (PEER)’s inaugural Hill Day to educate and speak to Congress about the importance of the ethical use of animals in biomedical research.
In Industry Insights, members of ASPET’s Industry Science Committee discuss the intersection of pharmacology and industry, private sector highlights, and how the industry and membership can support each other.
A showcase of early-career scientists—what drives them and why pharmacology is important to them.
The 38th Annual Meeting of the Great Lakes Chapter of the American Society for Pharmacology and Experimental Therapeutics (ASPET-GLC) was held at Northwestern University in Chicago on June 13, 2025. One hundred and seventy pharmacologists, biologists, computer scientists, chemists, clinicians, and students from both academia and the pharmaceutical industry in the Midwest were in attendance. To our knowledge, this was the highest meeting attendance ever at a GLC Annual Meeting, topping the previous high of 166 from 2024. Twenty-eight ASPET members attended, and an additional six attendees joined ASPET subsequent to the meeting.
New ASPET Journal Board Members, Announcing our new journal covers for 2026, New Special Section in The Journal of Pharmacology and Experimental Therapeutics Highlights Advances in Antithrombotic Therapy, New Special Issue of Molecular Pharmacology: “Emerging Voices in GPCR Biology”




